Category Archive for: ‘New Drug’

FDA Approves New Drug to Alleviate Moderate to Severe Pain

FDA NewsNovember 24, 2008 The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100 mg. “This approval offers health care professionals an additional choice for treating moderate to severe …

Read More

Lilly Pulls FDA Application For Cymbalta For Pain

Nov 28, 2008 CHICAGO (Reuters) – Eli Lilly and Co (LLY.N: Quote, Profile, Research, Stock Buzz) said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug’s effectiveness and dosing. Lilly said it made its decision to pull the supplemental New Drug Application for …

Read More